Biotinylated Recombinant Human TFPI Protein

Produktübersicht

• Artikelname: Biotinylated Recombinant Human TFPI Protein
• Artikelnummer: ABB-RP02066B
• Hersteller Artikelnummer: RP02066B
• Alternativnummer: ABB-RP02066B-100UG
• Hersteller: ABclonal
• Wirt: Human
• Kategorie: Proteine/Peptide
• Spezies Reaktivität: Human
• Immunogen: Asp29-Lys282
• Alternative Synonym: EPI, LACI, TFI, TFPI1,TFPI,LACI,TFI,TFPI1

Produktbeschreibung

Oestrogens influence the pathophysiology and development of hormone-sensitive cancers, such as breast cancer. Tissue factor pathway inhibitor (TFPI) is a serine protease inhibitor of the extrinsic coagulation pathway and has recently been associated with breast cancer cell development.

Produkteigenschaften

• Konzentration: < 1 EU/µg of the protein by LAL method.
• Molekulargewicht: 32.1 kDa
• NCBI: 7035
• UniProt: P10646
• Reinheit: 95 % as determined by Tris-Bis PAGE.
• Formulierung: Lyophilized from a 0.22 µm filtered solution of PBS, pH 7.4.
• Target-Kategorie: TFPI

Anwendungsbeschreibung

• Application Verdünnung: Lyophilized from a 0.22 µm filtered solution of PBS, pH 7.4.
• Anwendungsbeschreibung: Cross-Reactivity: Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage,it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA,5% HSA,10% FBS or 5% Trehalose),and aliquot the reconstituted protein solution to minimize free-thaw cycles., ResearchArea: Biosimilar Drug Targets

Bilder

Biotinylated Recombinant Human TFPI Protein was determined by Tris-Bis PAGE under reducing conditions.